280 related articles for article (PubMed ID: 28404670)
1. Intravitreal dexamethasone implant in radiation-induced macular oedema.
Frizziero L; Parrozzani R; Trainiti S; Pilotto E; Miglionico G; Pulze S; Midena E
Br J Ophthalmol; 2017 Dec; 101(12):1699-1703. PubMed ID: 28404670
[TBL] [Abstract][Full Text] [Related]
2. Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant.
Iacono P; Parodi MB; Scaramuzzi M; Bandello F
Br J Ophthalmol; 2017 Jun; 101(6):791-795. PubMed ID: 27625164
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
[TBL] [Abstract][Full Text] [Related]
4. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab for radiation-induced cystoid macular oedema in patients with nasopharyngeal carcinoma: a clinical series.
Subrayan V; Khaw KW; Peyman M; Koay AC; Tajunisah I
Ophthalmologica; 2013; 229(4):208-11. PubMed ID: 23548379
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
Bonfiglio V; Reibaldi M; Pizzo A; Russo A; Macchi I; Faro G; Avitabile T; Longo A
Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792
[TBL] [Abstract][Full Text] [Related]
7. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
8. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
[TBL] [Abstract][Full Text] [Related]
9. INTRAVITREAL DEXAMETHASONE IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO PLAQUE BRACHYTHERAPY IN CHOROIDAL MELANOMA.
Caminal JM; Flores-Moreno I; Arias L; Gutiérrez C; Piulats JM; Català J; Rubio MJ; Cobos E; García P; Pera J; Giralt J; Arruga J
Retina; 2015 Sep; 35(9):1890-7. PubMed ID: 26035401
[TBL] [Abstract][Full Text] [Related]
10. Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implant.
Busch C; Rehak M; Sarvariya C; Zur D; Iglicki M; Lima LH; Invernizzi A; Viola F; Agrawal K; Sinawat S; Couturier A; Mehta A; Juneja R; Jain H; Agarwal AK; Goel N; Nagpal M; Gupta V; Banker A; Loewenstein A; Okada M; Saatci AO; Mansour AM; Chhablani J
Br J Ophthalmol; 2019 Apr; 103(4):463-468. PubMed ID: 29891733
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma.
Shah SU; Shields CL; Bianciotto CG; Iturralde J; Al-Dahmash SA; Say EAT; Badal J; Mashayekhi A; Shields JA
Ophthalmology; 2014 Jan; 121(1):269-275. PubMed ID: 24139123
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone Intravitreal Implant Therapy for Retinal Vein Occlusion Macular Oedema and Conversion to Ranibizumab in Clinical Practice.
Balal S; Than J; Tekriwal S; Lobo A
Ophthalmologica; 2018; 239(1):36-44. PubMed ID: 28950262
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.
Kaplan RI; Chaugule SS; Finger PT
Br J Ophthalmol; 2017 Dec; 101(12):1694-1698. PubMed ID: 28416492
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal Sustained-Release Steroid Implants for the Treatment of Macular Edema following Surgical Removal of Epiretinal Membranes.
Hattenbach LO; Springer-Wanner C; Hoerauf H; Callizo J; Jungmann S; Brauns T; Fulle G; Eichel S; Koss MJ; Kuhli-Hattenbach C
Ophthalmologica; 2017; 237(4):232-237. PubMed ID: 28463851
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
Lee KH; Kang EC; Koh HJ
Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
[TBL] [Abstract][Full Text] [Related]
16. DEXAMETHASONE INTRAVITREAL IMPLANT VS RANIBIZUMAB IN THE TREATMENT OF MACULAR EDEMA SECONDARY TO BRACHYTHERAPY FOR CHOROIDAL MELANOMA.
Russo A; Reibaldi M; Avitabile T; Uva MG; Franco LM; Gagliano C; Bonfiglio V; Spatola C; Privitera G; Longo A
Retina; 2018 Apr; 38(4):788-794. PubMed ID: 28272283
[TBL] [Abstract][Full Text] [Related]
17. INTRAVITREAL DEXAMETHASONE (OZURDEX) IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO STEREOTACTIC RADIOTHERAPY FOR POSTERIOR UVEAL MELANOMA.
Koc I; Kadayifcilar S; Kiratli H; Eldem B
Retin Cases Brief Rep; 2019; 13(4):352-356. PubMed ID: 28489707
[TBL] [Abstract][Full Text] [Related]
18. Rapid response to dexamethasone intravitreal implant in diabetic macular edema.
Lo Giudice G; Avarello A; Campana G; Galan A
Eur J Ophthalmol; 2018 Jan; 28(1):74-79. PubMed ID: 28708221
[TBL] [Abstract][Full Text] [Related]
19. Monthly intravitreal bevacizumab for macular edema after iodine-125 plaque radiotherapy of uveal melanoma.
Mashayekhi A; Rojanaporn D; Al-Dahmash S; Shields CL; Shields JA
Eur J Ophthalmol; 2014; 24(2):228-34. PubMed ID: 23934823
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomised controlled clinical trial comparing a combination of repeated intravitreal Ozurdex and macular laser therapy versus macular laser only in centre-involving diabetic macular oedema (OZLASE study).
Heng LZ; Sivaprasad S; Crosby-Nwaobi R; Saihan Z; Karampelas M; Bunce C; Peto T; Hykin PG
Br J Ophthalmol; 2016 Jun; 100(6):802-7. PubMed ID: 26472406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]